Experimental or investigational appeal letter template
A free, fillable experimental or investigational appeal letter you can copy, complete, and send. It is built on the structure that actually wins experimental or investigational appeals, not a generic reconsideration request.
The experimental or investigational appeal letter template
Copy the template below and replace every bracketed field with your details. Keep it to one or two pages plus attachments.
[Date] [Your full name] [Your address] [Your phone] · [Your email] [Insurer name], Appeals Department [Appeals address from your denial letter] Re: Appeal of experimental or investigational denial Member: [Patient name] · Member ID: [Member ID] · Group: [Group #] Claim #: [Claim #] · Date(s) of service: [Date of service] Denial date: [Denial date] · Denial/reason code: [Code] To the Appeals Department: I am formally appealing [Insurer]'s [denial date] denial of [service or medication]. I request that the denial be overturned and the experimental or investigational approved. 1. The denial. [Insurer] denied this experimental or investigational stating, verbatim: "[paste the exact denial language from your letter]." 2. Why the denial is incorrect. [State, in one or two sentences, why the service is medically necessary for your condition, and answer the specific reason the plan gave.] 3. The controlling standard. [See the standard for this denial type below, then cite it here.] 4. The evidence. I am attaching: - A letter of medical necessity from my treating provider addressing each clinical criterion; - [Your supporting records: see the document checklist below]; - The clinical guidelines and records that support coverage. 5. My request. I request a full reversal of this denial and approval of [service or medication] within the timeframe required by law. If the denial is upheld, please provide in writing the specific clinical criteria used, the credentials of the reviewing clinician, and instructions for independent external review. Under 29 C.F.R. 2560.503-1 (employer plans) or 45 C.F.R. 147.136 (ACA plans), please also provide all documents and records relevant to this claim. Sincerely, [Patient name / authorized representative]
The controlling standard for experimental or investigational denials
FDA approval for the indication, recognized compendia (NCCN, AHFS-DI, DrugDex), and CMS National Coverage Determinations defeat an 'experimental or investigational' label.
What makes a experimental or investigational appeal letter win
Identify the plan's exact 'experimental/investigational' policy bulletin and rebut it point-by-point. Cite NCCN, ASCO, AHFS-DI, DrugDex, or other recognized compendia for the indication. Attach peer-reviewed literature and any clinical-trial enrollment data. Many state external review programs apply a heightened standard for E/I denials, once the case reaches external review, the IRO physician panel often overturns.
The letters that get overturned share a structure: they quote the denial, rebut the plan's specific criteria point by point, cite the controlling standard above, attach a treating-provider letter of medical necessity, and make a clear demand for reversal. Generic letters that simply ask the plan to reconsider do not move reviewers.
Documents to attach
- Denial letter (with plan's E/I policy bulletin)
- Treating physician's letter of medical necessity
- Peer-reviewed literature supporting the therapy
- Compendium entry (NCCN, ASCO, AHFS-DI, DrugDex)
- Pathology / diagnostic report
Skip the blank page
Apellica builds the full experimental or investigational appeal for you, with the criteria rebuttal, the controlling-standard citation, and the medical-necessity evidence pack assembled. $0 upfront, pay only if we win.
Build my appeal free →Experimental or investigational appeal: frequently asked questions
Can I appeal an 'experimental or investigational' denial from my insurer?
Yes, and these reverse often at external review. Identify the plan's exact experimental/investigational policy bulletin and rebut it point by point with FDA approval for the indication, recognized compendia, and peer-reviewed evidence.
What beats an 'experimental' label?
FDA approval for the specific indication, a recognized compendium entry (NCCN, AHFS-DI, DrugDex), a CMS national coverage determination, and peer-reviewed literature. Many state external-review programs apply a heightened standard for these denials.
How long do I have for an experimental-denial appeal?
Internal appeals are due within 180 days. External review is typically available within 4 months (120 days) of the final internal denial, and urgent cases qualify for 72-hour expedited review.
Why does my insurer call a standard treatment experimental?
Usually because the therapy is not specifically FDA-approved for that indication, the plan's bulletin lists it as investigational, or no randomized trial is cited in the policy. A compendium entry for your diagnosis directly contradicts that classification.